Diabetic Retinopathy: Current Pharmacologic Treatment and Emerging Strategies eBook

Delivery: Can be download immediately after purchasing. For new customer, we need process for verification from 30 mins to 12 hours.
Version: PDF/EPUB. If you need EPUB and MOBI Version, please contact us.
Compatible Devices: Can be read on any devices.

Diabetic Retinopathy
Current Pharmacologic Treatment and Emerging Strategies
A well-illustrated and comprehensive analysis of the treatment of diabetic retinopathy, this book covers current treatment options and guidelines, whilst also providing a detailed discussion of emerging therapeutic targets. Existing therapeutic options are covered in depth, with a major focus on anti-vascular endothelial growth factor drugs and sustained release corticosteroids, including a review of trial results supporting current treatment guidelines. The use of agents off-label is also discussed. Controversial topics are discussed in detail with an emphasis on helping the reader make informed decisions, particularly when treating patients for which several treatment approaches may be appropriate because trial data does not clearly define the best option. Emerging therapeutic areas are evaluated, as work continues to identify agents that produce superior morphologic responses and visual acuity gains by targeting other molecules that contribute to diabetic retinopathy. Promising new drugs, targets and delivery systems are identified, and their development analysed.

This is a digital product.

Diabetic Retinopathy: Current Pharmacologic Treatment and Emerging Strategies is written by Michael W. Stewart and published by Adis. The Digital and eTextbook ISBNs for Diabetic Retinopathy are 9789811035098, 9811035091 and the print ISBNs are 9789811035081, 9811035083.